{
    "organizations": [],
    "uuid": "17f36f7058d19d603e2c58b7f81e84a45a4c4e82",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eli-lilly-interested-in-immuno-onc/brief-eli-lilly-interested-in-immuno-oncology-deals-idUSL1N1S10ND",
    "ord_in_thread": 0,
    "title": "BRIEF-Eli Lilly Interested In Immuno-Oncology Deals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Eli Lilly and Co:\n* ELI LILLY AND CO CEO SAYS PLANS TO SHARE FINDINGS OF STRATEGIC REVIEW OF ANIMAL HEALTH BUSINESS IN JULY\n* ELI LILLY SAYS INTERESTED IN BUSINESS DEVELOPMENT INCLUDING DEALS IN IMMUNO-ONCOLOGY AND OTHER CANCER DRUGS Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)\n ",
    "published": "2018-04-24T22:02:00.000+03:00",
    "crawled": "2018-04-25T14:31:04.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "eli",
        "lilly",
        "co",
        "eli",
        "lilly",
        "co",
        "ceo",
        "say",
        "plan",
        "share",
        "finding",
        "strategic",
        "review",
        "animal",
        "health",
        "business",
        "july",
        "eli",
        "lilly",
        "say",
        "interested",
        "business",
        "development",
        "including",
        "deal",
        "cancer",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "bill",
        "berkrot"
    ]
}